Author:
Schumann Anke,Brutsche Marion,Havermans Monique,Grünert Sarah C.,Kölker Stefan,Groß Olaf,Hannibal Luciana,Spiekerkoetter Ute
Abstract
AbstractMethylmalonic aciduria (MMA-uria) is caused by deficiency of the mitochondrial enzyme methylmalonyl-CoA mutase (MUT). MUT deficiency hampers energy generation from specific amino acids, odd-chain fatty acids and cholesterol. Chronic kidney disease (CKD) is a well-known long-term complication. We exposed human renal epithelial cells from healthy controls and MMA-uria patients to different culture conditions (normal treatment (NT), high protein (HP) and isoleucine/valine (I/V)) to test the effect of metabolic stressors on renal mitochondrial energy metabolism. Creatinine levels were increased and antioxidant stress defense was severely comprised in MMA-uria cells. Alterations in mitochondrial homeostasis were observed. Changes in tricarboxylic acid cycle metabolites and impaired energy generation from fatty acid oxidation were detected. Methylcitrate as potentially toxic, disease-specific metabolite was increased by HP and I/V load. Mitophagy was disabled in MMA-uria cells, while autophagy was highly active particularly under HP and I/V conditions. Mitochondrial dynamics were shifted towards fission. Sirtuin1, a stress-resistance protein, was down-regulated by HP and I/V exposure in MMA-uria cells. Taken together, both interventions aggravated metabolic fingerprints observed in MMA-uria cells at baseline. The results point to protein toxicity in MMA-uria and lead to a better understanding, how the accumulating, potentially toxic organic acids might trigger CKD.
Funder
Deutsche Forschungsgemeinschaft, Germany
Nutricia Metabolics Research Fund
Freiburg Center for Rare Diseases
Division of Inborn Errors of Metabolism at the Department of Pediatrics
Universitätsklinikum Freiburg
Publisher
Springer Science and Business Media LLC
Reference55 articles.
1. Forny, P. et al. Guidelines for the diagnosis and management of methylmalonic acidaemia ***and propionic acidaemia: First revision. J. Inherit. Metab. Dis. 44(3), 566–592 (2021).
2. Dimitrov, B. et al. Organic acidurias: Major gaps, new challenges, and a yet unfulfilled promise. J. Inherit. Metab. Dis. 44(1), 9–21 (2021).
3. Hörster, F. et al. Delineating the clinical spectrum of isolated methylmalonic acidurias: cblA and mut. J. Inherit. Metab. Dis. 44(1), 193–214 (2021).
4. Hörster, F. et al. Long-term outcome in methylmalonic acidurias is influenced by the underlying defect (mut0, mut-, cblA, cblB). Pediatr. Res. 62(2), 225–230 (2007).
5. Richard, E. et al. Altered redox homeostasis in branched-chain amino acid disorders, organic acidurias, and homocystinuria. Oxid. Med. Cell. Longev. 20, 1246069 (2018).
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献